Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rhythm Pharmaceuticals (RYTM) Revenue: 2021-2024

Historic Revenue for Rhythm Pharmaceuticals (RYTM) over the last 4 years, with Dec 2024 value amounting to $130.1 million.

  • Rhythm Pharmaceuticals' Revenue rose 54.28% to $51.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $174.3 million, marking a year-over-year increase of 54.92%. This contributed to the annual value of $130.1 million for FY2024, which is 68.06% up from last year.
  • As of FY2024, Rhythm Pharmaceuticals' Revenue stood at $130.1 million, which was up 68.06% from $77.4 million recorded in FY2023.
  • In the past 5 years, Rhythm Pharmaceuticals' Revenue ranged from a high of $130.1 million in FY2024 and a low of $3.2 million during FY2021.
  • Over the past 3 years, Rhythm Pharmaceuticals' median Revenue value was $77.4 million (recorded in 2023), while the average stood at $77.1 million.
  • Data for Rhythm Pharmaceuticals' Revenue shows a peak YoY spiked of 649.46% (in 2022) over the last 5 years.
  • Over the past 4 years, Rhythm Pharmaceuticals' Revenue (Yearly) stood at $3.2 million in 2021, then skyrocketed by 649.46% to $23.6 million in 2022, then soared by 227.56% to $77.4 million in 2023, then skyrocketed by 68.06% to $130.1 million in 2024.